← Back to all trials
Completed
NCT04844359
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
Conditions: Hypersensitivity Pneumonitis
Sex: All
Ages: 18 Years – 85 Years
Healthy volunteers: No
Enrollment: 137
Sponsor: National Jewish Health
Location: University of Arizona Tucson Arizona
Summary
Up to 150 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of chronic hypersensitivity pneumonitis
* Age 18 through 85 years.
* Diagnosis of chronic hypersensitivity pneumonitis by HRCT
* Able to understand and sign a written informed consent form.
* Able to understand the importance of adherence to the study protocol and willing to follow all study requirements
Exclusion Criteria:
* Not a suitable candidate for enrollment or unlikely to comply with the requirements of this study
* Known explanation for the interstitial lung disease
* Clinical diagnosis of any connective tissue disease
* Listed or expected to receive a lung transplant within 4 months from enrollment
* Pregnant women
Source: ClinicalTrials.gov (NCT04844359). StuddyBuddy aggregates publicly available trial information.